Citydiabetes, Serafen

Research site

Sweden Hantverkagatan 2D, 112 21 Stockholm, Sweden

Type 2 diabetes mellitus
Adult patients

About Specializations

Citydiabetes, Serafen in Stockholm, Sweden specialises in clinical trials of conditions such as Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Type 2 diabetes mellitus

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Hantverkagatan 2D112 21 StockholmSweden

Open in maps ↗

Recruiting now: no trials
Conditions studied: 1

More sites in Stockholm Sweden

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Dulaglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites